Physician profile
Elin C Beck
NPI 1982196614
$26,733.75
in general payments reported to CMS, 2019-2025
7 companies · $15K in 2025
The $15K reported for 2025 was more than what 99% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $12K · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $24K · Food and Beverage: $2,085 · Education: $340 · Travel and Lodging: $88.88.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $24,219.70 |
| Food and Beverage | $2,084.69 |
| Education | $340.48 |
| Travel and Lodging | $88.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $14,274.68 | 2024-2025 | Tacticath, Assurity, Mitraclip |
| Medtronic, INC. | $8,919.47 | 2024-2025 | Aurora Ev-Icd Mri Surescan |
| Boston Scientific Corporation | $2,978.29 | 2024-2025 | Watchman Access System, General - Therapies |
| Biosense Webster, INC. | $387.07 | 2024-2025 | Carto 3, Qdot Micro |
| Amgen INC. | $127.18 | 2024 | |
| Cardiva Medical, INC. | $25.46 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Biotronik INC. | $21.60 | 2025 | Selectra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elin Beck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.